An Australian stem cell and regenerative medicine company

ASX Announcements

07 May 2019 Appendix 3Y-Dr John Chiplin
07 May 2019 Cleansing Notice
07 May 2019 Appendix 3B-Exercise of Options
06 May 2019 CYP Progresses Start-Up Activities for Clinical Trial in CLI
26 Apr 2019 March 2019 Quarterly Report
04 Apr 2019 European Patent Issued to Cynata Therapeutics
21 Mar 2019 Extension of FUJIFILM Licence Option in GvHD
21 Mar 2019 Cleansing Notice
21 Mar 2019 Cynata Extends FUJIFILM Licence Option in GvHD
20 Mar 2019 Appendix 3B-Exercise of Options
19 Mar 2019 Trading Halt
13 Mar 2019 Cleansing Notice
13 Mar 2019 Appendix 3B-Exercise of Options
12 Mar 2019 Cynata Receives Favourable Advice on Planned CLI Trial
11 Mar 2019 Joint Study of Cynata MSCs receives VMRAF Funding
04 Mar 2019 Positive Pre-Clinical Coronary Artery Disease Data for CYP
27 Feb 2019 Appendix 4D & Half-Year Financial Statements
25 Feb 2019 Further Cynata Asthma Study Published
22 Feb 2019 Cleansing Notice
22 Feb 2019 Appendix 3B-Exercise of Options
18 Feb 2019 Cleansing Notice
18 Feb 2019 Appendix 3B-Exercise of Options
11 Feb 2019 Appendix 3Y-Dr John Chiplin
11 Feb 2019 Cleansing Notice
11 Feb 2019 Appendix 3B-Exercise of Options
07 Feb 2019 Study of CYP-001 Published in Leading Peer Review Journal
04 Feb 2019 Cleansing Notice
04 Feb 2019 Appendix 3B-Exercise of Options
29 Jan 2019 December 2018 Quarterly Report
29 Jan 2019 Clinical trial results to be presented at major symposium
07 Jan 2019 CYP Receives Notice of Acceptance from Aust Patent Office
20 Dec 2018 End of Year Newsletter
18 Dec 2018 Cynata Completes Clinical Study Report in GvHD
13 Dec 2018 NHMRC Funding for Osteoarthritis Trial Using Cymerus MSCs
19 Nov 2018 Cynata Receives $1.3m R&D Tax Incentive Refund
15 Nov 2018 Replacement-Results of Annual General Meeting
15 Nov 2018 Results of Annual General Meeting
15 Nov 2018 Chairman's AGM Address
15 Nov 2018 Annual General Meeting Presentation
07 Nov 2018 CYP Receives Notice of Allowance from European Patent Office
01 Nov 2018 Cynata Clinical Trial Data Accepted for presentation at ASH
01 Nov 2018 Cynata Outlook and Investor Presentation
26 Oct 2018 Appendix 3Y-Dr Paul Wotton
23 Oct 2018 September 2018 Quarterly Report
17 Oct 2018 MSCs Demonstrate Anti-Cancer Effects in Pre-Clinical Studies
11 Oct 2018 Annual Report to Shareholders
11 Oct 2018 Notice of Annual General Meeting/Proxy Form
26 Sep 2018 Notification of 2018 Annual General Meeting Date
25 Sep 2018 Appendix 3Y-Stewart Washer
25 Sep 2018 Appendix 3Y-Dr Ross Macdonald